Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma
Approximately 25% to 40% of patients with chronic obstructive pulmonary disease (COPD) have the eosinophilic endotype. It is important to identify this group accurately because they are more symptomatic and are at increased risk for exacerbations and accelerated decline in forced expiratory volume i...
Guardado en:
Autores principales: | Andrew Li, Hiang Ping Chan, Phyllis X.L. Gan, Mei Fong Liew, W.S. Fred Wong, Hui-Fang Lim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
The Korean Association of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73dee75f007948f68c61dda89afb3cae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
por: Choi JH, et al.
Publicado: (2021) -
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
por: Kahnert K, et al.
Publicado: (2021) -
Considerations for managing chronic obstructive pulmonary disease in the elderly
por: Taffet GE, et al.
Publicado: (2013) -
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
por: Fabrizio Facchinetti, et al.
Publicado: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Priyadarshini Kachroo, et al.
Publicado: (2021)